Company Novo Medica Srl with Fiscal Code 14556406
recorded a turnover of 2024 of
345.222,
with a net profit of
58.591
and having an average number of employees of
5.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novo Medica Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
145.649
174.196
228.709
234.833
265.517
202.168
283.668
297.645
301.241
345.222
Total Income - EUR
147.166
178.894
230.503
237.609
265.779
202.178
283.683
300.654
302.760
349.651
Total Expenses - EUR
117.084
138.690
146.479
173.648
186.497
170.063
194.078
236.863
235.689
281.696
Gross Profit/Loss - EUR
30.082
40.204
84.024
63.961
79.282
32.114
89.605
63.791
67.070
67.955
Net Profit/Loss - EUR
23.360
34.073
69.986
61.611
76.627
30.236
86.828
61.206
64.376
58.591
Employees
3
3
4
4
4
3
5
6
6
5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 15.2%, from 301.241 euro in the year 2023, to 345.222 euro in 2024.
The Net Profit decreased by -5.425 euro, from 64.376 euro in 2023, to 58.591 in the last year.
Check the financial reports for the company - Novo Medica Srl
Financial Rating - NOVO MEDICA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novo Medica Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novo Medica Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novo Medica Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novo Medica Srl - CUI 14556406
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
126.931
330.945
314.937
402.040
394.815
378.813
403.863
397.757
380.947
358.940
Current Assets
24.508
31.282
80.861
33.098
38.501
18.508
26.926
64.459
116.655
152.872
Inventories
0
0
0
0
54
0
6.028
1.697
7.659
7.863
Receivables
1.793
11.403
567
1.716
2.521
1.559
7.045
5.019
13.099
4.536
Cash
22.715
19.879
80.294
31.382
35.926
16.949
13.853
57.743
95.896
29.904
Shareholders Funds
69.145
102.513
160.914
219.572
290.657
304.502
373.937
414.958
448.964
473.580
Social Capital
135
134
131
129
126
124
121
122
121
121
Debts
83.186
260.463
234.884
216.019
143.491
92.819
56.969
47.440
48.710
38.279
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
152.872 euro in 2024 which includes Inventories of
7.863 euro, Receivables of
4.536 euro and cash availability of
29.904 euro.
The company's Equity was valued at
473.580 euro, while total Liabilities amounted to
38.279 euro.
Equity increased by 27.125 euro, from 448.964 euro in 2023, to 473.580 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novo Medica Srl